A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2006
10/25/2006	CN1850270A Ovotransferrin iron supplement agent, and its preparing method and use
10/25/2006	CN1850266A Chinese patent medicine for treating nephritis damp swelling syndrome and preparing method
10/25/2006	CN1850231A Longxuejie granules and its preparing technology
10/25/2006	CN1850208A Quality control method for ass-skin glue blood-supplementing preparation
10/25/2006	CN1850192A Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method
10/25/2006	CN1850175A Method for preparing Radix-paeoniae-rubra formula granules
10/25/2006	CN1850170A Compounded Folium Pyrrosiae capsule preparing method and its quality controlling technology
10/25/2006	CN1850155A Dispersible tablet of clinopodium polycephalum, and its preparing method
10/25/2006	CN1850154A Liquid capsule of Radix seu Herba Phlomis Rotatae and preparing method
10/25/2006	CN1850117A Method for preparing enteric coatal administration preparation of tortoise-shell glue, deerhorn glue and carapax amydae turtle shell glue and use thereof
10/25/2006	CN1850114A Method for ass-skin-glue colon administration preparation and use thereof
10/25/2006	CN1850111A Biodegradeable hemostasis powder
10/25/2006	CN1850097A Scutellarin injection preparation and its preparing method
10/25/2006	CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor
10/25/2006	CN1850078A Anti-platelet aggregation medicinal injection and its preparing method
10/25/2006	CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006	CN1850069A Method for preparing Tengchasu dispersibletablet and its use
10/25/2006	CN1850068A Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method
10/25/2006	CN1281743C Preparation method of earthworm kinase dry powder
10/25/2006	CN1281624C Thrombin derivatives and its process for production
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias
10/25/2006	CN1281236C Chinese medicinal decoction for treating embolus disease
10/25/2006	CN1281224C Cinese medicine increasing leucocyte and preparation thereof
10/25/2006	CN1281215C The second purpose of Siberian solomonseal rhizome polysaccharide
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125862 Porphyrin-metal complexes and oxygen infusions containing the same
10/19/2006	WO2006110483A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109698A1 Composition comprising genetically engineered erythropoietin
10/19/2006	WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006	WO2006109592A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006	WO2006108709A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
10/19/2006	WO2006108670A2 Use of cd25 antibodies in immunotherapy
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
10/19/2006	US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	US20060233896 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, Cistanche tubulosa (Schenk.) Wight, process of making the same, and uses of the same
10/19/2006	US20060233884 Sexual hygienic composition
10/19/2006	US20060233877 Betaine compositions
10/19/2006	US20060233869 Biocompatible, oxidized cellulose particles of specific size; and porous water soluble or water swellable polysaccharide binder; controlling post-surgical bleeding; medical equipment
10/19/2006	US20060233841 Implantable gel compositions and method of manufacture
10/19/2006	US20060233799 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
10/19/2006	US20060233786 Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA
10/19/2006	US20060233706 Marked peptides having affinity for a phospholipid and uses
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2603402A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	CA2603264A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006	CA2600709A1 Use of cd25 antibodies in immunotherapy
10/18/2006	EP1712237A2 Erythropoietin solution preparation stabilized with leucine, glutamic acid or lysine
10/18/2006	EP1712226A2 Treatment of a Hemoglobinopathy
10/18/2006	EP1712221A1 Support accumulating in injured part in vascular channel
10/18/2006	EP1711454A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
10/18/2006	EP1641421A4 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content
10/18/2006	EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1212352B1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849133A Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
10/18/2006	CN1849114A Topical preparations comprising a hydrophilic carrier and a silicone matrix
10/18/2006	CN1847236A 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use
10/18/2006	CN1847230A Water soluble cinnarizine salt and its injection form
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846783A Compound piracetam-cerebral protein hydrolysate capsule and its prepn
10/18/2006	CN1846776A Injection of long-chain fat from zedoary oil and its prepn process
10/18/2006	CN1846735A Recipe of Chinese herbal medicine for lowering lipid and dissolving thrombus
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846696A Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/18/2006	CN1280309C Erythropoietin with high specific activity
10/18/2006	CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1279963C Process for preparing product containing antiinflammatory, anticoagulant and antibacterial components from ginger and its product and medical composition
10/18/2006	CN1279960C Medicine for treating hemorrhagic disease and its preparing method
10/18/2006	CN1279956C Hematogenesis agent for ladies and technique of preparing capsules
10/18/2006	CN1279950C Compound formula earthworm capsule and its preparation technology
10/18/2006	CN1279944C Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation
10/18/2006	CN1279935C Prpearation method of xueshuan xinmoining Chinese medicine for curing cerebrovascular diseases
10/17/2006	US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006	US7122529 Administering compound; irradiation with light of selective wavelength; deactivating pathogens in blood
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122210 A concentrate solution comprising sodium bicarbonate concentrate, electrolyte concentrate; treating renal failure with hemofiltration
10/17/2006	CA2317038C Supplement for dialysis patients

1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 671